Systematic review of screening for bilirubin encephalopathy in neonates

Pediatrics

Volumn 124, Issue 4, 2009, Pages 1162-1171

  Trikalinos, Thomas A ^a   Chung, Mei ^a   Lau, Joseph ^a   Ip, Stanley ^a,b  

^a Institute for Clinical Research and Health Policy Studies   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Bilirubin encephalopathy; Hyperbilirubinemia; Kernicterus; Screening

Indexed keywords

BILIRUBIN;

ACUTE DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC DISEASE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HOSPITAL READMISSION; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; MEDICAL LIABILITY; MEDICAL RESEARCH; MORBIDITY; NEWBORN SCREENING; PHOTOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ACUTE DISEASE; BILIRUBIN; BOSTON; BRAIN DAMAGE, CHRONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; KERNICTERUS; MALE; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 70349754459     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3545     Document Type: Article

References (25)

1. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004;114(1):297-316
2. Ip S, Glicken S, Kulig J, O'Brien R, Sege R. Management of neonatal hyperbilirubinemia. Evid Rep Technol Assess (Summ). 2003;(65):1-5
3. Kernicterus threatens healthy newborns. Sentinel Event Alert. 2001;(18):1-4
4. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006;35(4):444-455 (Pubitemid 44874940)
5. Chou SC, Palmer RH, Ezhuthachan S, et al. Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model. Pediatrics. 2003;112(6 pt 1):1264-1273 (Pubitemid 37523405)
6. Ip S, Chung M, Kulig J, et al; American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1). Available at: www.pediatrics.org/cgi/content/full/114/1/e130
7. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 suppl):21-35 (Pubitemid 33732964)
8. Ip S, Chung M, Trikalinos T, DeVine D, Lau J. Screening for Bilirubin Encephalopathy. Evidence Synthesis No. 72. AHRQ Publication No. 09-05136-EF-1. Rockville, Maryland: Agency for Healthcare Research and Quality, October 2009
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310 (Pubitemid 16134762)
10. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135-160 (Pubitemid 29425900)
11. Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004; 8(25):iii, 1-234 (Pubitemid 38967660)
12. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703-707 (Pubitemid 24061707)
13. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90(4):415-421 (Pubitemid 40488685)
14. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159(2):113-119 (Pubitemid 40194175)
15. Sarici SU, Serdar MA, Korkmaz A, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics. 2004;113(4):775-780 (Pubitemid 38437383)
16. Agarwal R, Kaushal M, Aggarwal R, Paul VK, Deorari AK. Early neonatal hyperbilirubinemia using first day serum bilirubin level. Indian Pediatr. 2002;39(8):724-730
17. Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. J Med Assoc Thai. 2005;88(9):1187-1193 (Pubitemid 43154715)
18. Petersen JR, Okorodudu AO, Mohammad AA, Fernando A, Shattuck KE. Association of transcutaneous bilirubin testing in hospital with decreased readmission rate for hyperbilirubinemia. Clin Chem. 2005;51(3):540-544 (Pubitemid 40300229)
19. Ho HT, Ng TK, Tsui KC, Lo YC. Evaluation of a new transcutaneous bilirubinometer in Chinese newborns. Arch Dis Child Fetal Neonatal Ed. 2006;91(6):F434-F438
20. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospitaldischarge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117(5). Available at: www.pediatrics.org/cgi/content/full/117/5/e855 (Pubitemid 46071352)
21. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154(11):1140-1147 (Pubitemid 30828101)
22. Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA. 1999;282(8):771-778 (Pubitemid 29404385)
23. Pauker SG. Deciding about screening. Ann Intern Med. 1993;118(11):901-902
24. Suresh GK, Clark RE. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants. Pediatrics. 2004;114(4):917-924
25. Manning D, Todd P, Maxwell M, Jane PM. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92(5):F342-F346 (Pubitemid 47436215)